This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of State's Office of Global Acquisitions, Acquisitions Management (A/GA/AM) on behalf of the Office of Global Operations, Logistics Operations and Supply Chain Management (A/GO/OPS/SCM) to BioFire Defense LLC, a manufacturer of in-vitro diagnostic products. The single-award BPA, valued up to $4,500,000, procures specialized laboratory testing supplies from BioFire Defense including FilmArray RP2.1 panel tests, Gastrointestinal Panel Tests, Global Fever Special Pathogens Tests, and related control kits. This sole-source acquisition is justified under FAR 8.405-6(a)(1)(i)(B) as the supplies are deemed unique or highly specialized, with BioFire as the only capable vendor. The BPA has a 2-year performance period from March 2025 through March 2027 and supports the Department of State's ability to conduct medical testing at embassies worldwide using BioFire's self-contained test pouches. No set-asides were used for this award.
The acquisition was originally announced via a Special Notice, with interested parties invited to submit capability statements by December 15, 2024. The notice indicates the BPA will be issued against BioFire's Federal Supply Schedule contract. This procurement aligns with BioFire's history of providing biological threat detection, infectious disease testing, and public health preparedness solutions to various federal agencies, including the Department of Defense, Department of Health and Human Services, and others, through prior prime contracts, subcontracts, and grants.
Generated 3/6/25, 10:12 AM